ClinicalTrials.Veeva

Menu

Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38

U

University of Cagliari

Status

Completed

Conditions

Spinocerebellar Ataxias

Treatments

Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05951010
tDCS-ATX

Details and patient eligibility

About

Spinocerebellar ataxia 38 (SCA 38) is a very rare autosomal dominant inherited disorder caused by a mutation in ELOV5 gene, specifically expressed in cerebellar Purkinje cells, encoding an enzyme involved in the synthesis of fatty acids. The present study aimed to assess the effect of cerebellar anodal transcranial direct current stimulation (tDCS) administered employing deltoid (CD-tDCS) and spinal (CS-tDCS) cathodal montage. Clinical evaluation was performed at baseline (T0), after 15 sessions of tDCS (T1) and after one month of follow-up (T2).

Enrollment

7 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age ≤ 80 and > 18 years
  2. diagnosis of SCA 38 with the presence of clinical symptoms.

Exclusion criteria

  1. Inability to understand and sign the informed consent
  2. Presence of other severe neurological disorders
  3. presence of significant medical or psychiatric illnesses
  4. Pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

7 participants in 1 patient group

Transcranial direct current stimulation (tDCS)
Experimental group
Description:
Participants underwent anodal stimulation delivered by a battery-driven stimulator (Neuroelectrics, Barcellona, Spain) through a pair of saline-soaked surface sponge electrodes (7 x 5 cm2) producing a constant current of 2 mA for 20 min.
Treatment:
Device: Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems